SPECIAL COVERAGE — Biologics
CDMO World > Biologics, india, syngene, zydus > NEWS CAPSULES: India CDMO Biologics Expansion & Market Moves

NEWS CAPSULES: India CDMO Biologics Expansion & Market Moves

India’s biologics CDMO sector is rapidly scaling through global acquisitions, new facilities, and surging demand. This capsule covers the country’s top moves.

NEWS CAPSULES: India CDMO Biologics Market News

August 4, 2025

The global biologics CDMO market continues to surge in 2025 as demand rises for monoclonal antibodies, mRNA, and viral vector manufacturing. These global CDMO capsules spotlight major facility expansions and strategic repositioning efforts by industry leaders.

Capsule 1: Biologics CDMO Market Set to Hit $27B

Strong growth in mAbs, gene therapy, and biosimilars will nearly double the CDMO biologics sector by 2028, according to Research and Markets.

Capsule 2: Samsung Biologics Opens Largest CDMO Plant

Samsung’s Plant 4 in Incheon pushes capacity beyond 600,000L, offering end-to-end solutions for high-volume biologics production.

Capsule 3: Catalent Considers Biologics Spin-off

Catalent announces it may divest portions of its biologics division amid FDA concerns and a company-wide operational review.

Capsule 4: WuXi Biologics Expands in Asia

WuXi unveils new mRNA and ADC manufacturing lines in Singapore and Wuxi to meet global demand and diversify risk outside China.

Internal Link: Explore more biologics news at CDMOworld.com

Image placeholder

Lorem ipsum amet elit morbi dolor tortor. Vivamus eget mollis nostra ullam corper. Pharetra torquent auctor metus felis nibh velit. Natoque tellus semper taciti nostra. Semper pharetra montes habitant congue integer magnis.

User avatar placeholder
Written by CDMO

Small-Batch Biologics CDMO Capacity: A Game-Changer for Emerging Biotech

NEWS CAPSULES: China CDMO Pharmaceutical Manufacturing – August 2025

Categories

Latest Articles

Subscribe to Newsletter

The Latest 

		[{"id":55295,"link":"https:\/\/cdmoworld.com\/single-use-systems-extractables-leachables-strategy-cdmo\/","name":"single-use-systems-extractables-leachables-strategy-cdmo","thumbnail":{"url":"https:\/\/cdmoworld.com\/wp-content\/uploads\/2026\/03\/Untitled-design-81.png","alt":"A group of scientists in lab coats and protective gear working together in a modern lab, performing research with test tubes, a microscope, and pipettes."},"title":"Single-Use Systems in Biologics Manufacturing: Extractables\/Leachables Strategy for CDMO","postMeta":[],"author":{"name":"CDMO World","link":"https:\/\/cdmoworld.com\/author\/raismrafiq\/"},"date":"Mar 6, 2026","dateGMT":"2026-03-06 12:24:58","modifiedDate":"2026-03-06 12:24:58","modifiedDateGMT":"2026-03-06 12:24:58","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/cdmoworld.com\/category\/qa\/\" rel=\"category tag\">Q&A<\/a>","space":"<a href=\"https:\/\/cdmoworld.com\/category\/qa\/\" rel=\"category tag\">Q&A<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/cdmoworld.com\/tag\/biologics-manufacturing\/' rel='post_tag'>Biologics Manufacturing<\/a><a href='https:\/\/cdmoworld.com\/tag\/cdmo\/' rel='post_tag'>CDMO<\/a><a href='https:\/\/cdmoworld.com\/tag\/cgmp-compliance\/' rel='post_tag'>cGMP Compliance<\/a><a href='https:\/\/cdmoworld.com\/tag\/regulatory-compliance\/' rel='post_tag'>Regulatory Compliance<\/a><a href='https:\/\/cdmoworld.com\/tag\/tech-transfer\/' rel='post_tag'>Tech Transfer<\/a><a href='https:\/\/cdmoworld.com\/tag\/testing\/' rel='post_tag'>Testing<\/a>","content-type":"<a href='https:\/\/cdmoworld.com\/content-type\/articles\/' rel='content-type'>Articles<\/a>"},"readTime":{"min":8,"sec":12},"status":"publish","excerpt":"Transitioning to Single-Use Systems (SUS) offers speed but introduces chemical risks. This 2,500-word Q&A-style guide provides a comprehensive Extractables and Leachables Strategy for sponsors working with CDMOs. Discover expert tips on risk assessment, USP compliance, and analytical validation to ensure patient safety in biologics manufacturing."},{"id":55294,"link":"https:\/\/cdmoworld.com\/drug-substance-vs-drug-product-comparability-cdmo\/","name":"drug-substance-vs-drug-product-comparability-cdmo","thumbnail":{"url":"https:\/\/cdmoworld.com\/wp-content\/uploads\/2026\/03\/Untitled-design-80.png","alt":"A digital illustration contrasting drug substance and drug product, with vials of blue liquid on the left representing drug substance, and vials with capsules and tablets on the right representing drug products, all set in a futuristic lab environment."},"title":"Drug Substance vs Drug Product Comparability: How CDMO Changes Expand Your Study Scope","postMeta":[],"author":{"name":"CDMO World","link":"https:\/\/cdmoworld.com\/author\/raismrafiq\/"},"date":"Mar 6, 2026","dateGMT":"2026-03-06 12:09:04","modifiedDate":"2026-03-06 12:09:18","modifiedDateGMT":"2026-03-06 12:09:18","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/cdmoworld.com\/category\/tips\/\" rel=\"category tag\">Tips<\/a>","space":"<a href=\"https:\/\/cdmoworld.com\/category\/tips\/\" rel=\"category tag\">Tips<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/cdmoworld.com\/tag\/biologics-manufacturing\/' rel='post_tag'>Biologics Manufacturing<\/a><a href='https:\/\/cdmoworld.com\/tag\/cdmo\/' rel='post_tag'>CDMO<\/a><a href='https:\/\/cdmoworld.com\/tag\/cgmp-compliance\/' rel='post_tag'>cGMP Compliance<\/a><a href='https:\/\/cdmoworld.com\/tag\/regulatory-compliance\/' rel='post_tag'>Regulatory Compliance<\/a><a href='https:\/\/cdmoworld.com\/tag\/tech-transfer\/' rel='post_tag'>Tech Transfer<\/a><a href='https:\/\/cdmoworld.com\/tag\/testing\/' rel='post_tag'>Testing<\/a>","content-type":"<a href='https:\/\/cdmoworld.com\/content-type\/articles\/' rel='content-type'>Articles<\/a>"},"readTime":{"min":7,"sec":11},"status":"publish","excerpt":"Navigating the nuances of Drug Substance vs Drug Product Comparability is vital when switching CDMOs. This 2,500-word guide provides expert tips on expanding your study scope. Learn how manufacturing changes impact analytical bridging and how to build a regulatory-compliant comparability plan that ensures safety for biologics."},{"id":55290,"link":"https:\/\/cdmoworld.com\/plasmid-dna-tech-transfer-cdmo-guide\/","name":"plasmid-dna-tech-transfer-cdmo-guide","thumbnail":{"url":"https:\/\/cdmoworld.com\/wp-content\/uploads\/2026\/03\/Untitled-design-79.png","alt":"A hand holding tweezers is shown cutting DNA strands, symbolizing genetic engineering and plasmid DNA technology transfer in a lab setting."},"title":"Plasmid DNA Tech Transfer to a CDMO: Process, Controls, and Release Testing","postMeta":[],"author":{"name":"CDMO World","link":"https:\/\/cdmoworld.com\/author\/raismrafiq\/"},"date":"Mar 6, 2026","dateGMT":"2026-03-06 11:49:25","modifiedDate":"2026-03-06 11:49:25","modifiedDateGMT":"2026-03-06 11:49:25","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/cdmoworld.com\/category\/sectors\/technology-transfer\/\" rel=\"category tag\">Technology Transfer<\/a>","space":"<a href=\"https:\/\/cdmoworld.com\/category\/sectors\/technology-transfer\/\" rel=\"category tag\">Technology Transfer<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/cdmoworld.com\/tag\/biologics-manufacturing\/' rel='post_tag'>Biologics Manufacturing<\/a><a href='https:\/\/cdmoworld.com\/tag\/bioprocess-development\/' rel='post_tag'>Bioprocess Development<\/a><a href='https:\/\/cdmoworld.com\/tag\/cdmo\/' rel='post_tag'>CDMO<\/a><a href='https:\/\/cdmoworld.com\/tag\/cgmp-compliance\/' rel='post_tag'>cGMP Compliance<\/a><a href='https:\/\/cdmoworld.com\/tag\/regulatory-compliance\/' rel='post_tag'>Regulatory Compliance<\/a><a href='https:\/\/cdmoworld.com\/tag\/tech-transfer\/' rel='post_tag'>Tech Transfer<\/a>","content-type":"<a href='https:\/\/cdmoworld.com\/content-type\/articles\/' rel='content-type'>Articles<\/a>"},"readTime":{"min":8,"sec":36},"status":"publish","excerpt":"Plasmid DNA is the backbone of modern gene therapy and mRNA vaccine production. This 2,500-word technical guide explores the complexities of Plasmid DNA Tech Transfer to a CDMO. We analyze critical process parameters, analytical validation, and release testing requirements to ensure your scale-up meets global regulatory standards."},{"id":55285,"link":"https:\/\/cdmoworld.com\/adventitious-agent-testing-biologics-cdmo-strategy\/","name":"adventitious-agent-testing-biologics-cdmo-strategy","thumbnail":{"url":"https:\/\/cdmoworld.com\/wp-content\/uploads\/2026\/03\/Untitled-design-78.png","alt":"A researcher holding a test tube while examining cancerous cells under a microscope, illustrating biological research and testing in a lab environment."},"title":"Adventitious Agent Testing in Biologics: Building a CDMO Testing Strategy That Regulators Accept","postMeta":[],"author":{"name":"CDMO World","link":"https:\/\/cdmoworld.com\/author\/raismrafiq\/"},"date":"Mar 6, 2026","dateGMT":"2026-03-06 11:32:43","modifiedDate":"2026-03-06 12:11:12","modifiedDateGMT":"2026-03-06 12:11:12","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/cdmoworld.com\/category\/sectors\/quality-control\/\" rel=\"category tag\">Quality Control<\/a>","space":"<a href=\"https:\/\/cdmoworld.com\/category\/sectors\/quality-control\/\" rel=\"category tag\">Quality Control<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/cdmoworld.com\/tag\/adventitious-agent-testing\/' rel='post_tag'>Adventitious Agent Testing<\/a><a href='https:\/\/cdmoworld.com\/tag\/biologics-manufacturing\/' rel='post_tag'>Biologics Manufacturing<\/a><a href='https:\/\/cdmoworld.com\/tag\/cdmo\/' rel='post_tag'>CDMO<\/a><a href='https:\/\/cdmoworld.com\/tag\/cgmp-compliance\/' rel='post_tag'>cGMP Compliance<\/a><a href='https:\/\/cdmoworld.com\/tag\/quality-control\/' rel='post_tag'>Quality Control<\/a><a href='https:\/\/cdmoworld.com\/tag\/regulatory-compliance\/' rel='post_tag'>Regulatory Compliance<\/a>","content-type":"<a href='https:\/\/cdmoworld.com\/content-type\/articles\/' rel='content-type'>Articles<\/a>"},"readTime":{"min":8,"sec":3},"status":"publish","excerpt":"Protecting biologics from viral, bacterial, and fungal contaminants is a regulatory mandate. This 2,500-word guide details Adventitious Agent Testing strategies at CDMOs. Explore in vitro and in vivo assays, Next-Generation Sequencing (NGS) trends, and how to structure your testing program to ensure safety and clinical success."},{"id":55283,"link":"https:\/\/cdmoworld.com\/rapid-mycoplasma-methods-biologics-qc-validation\/","name":"rapid-mycoplasma-methods-biologics-qc-validation","thumbnail":{"url":"https:\/\/cdmoworld.com\/wp-content\/uploads\/2026\/03\/Untitled-design-77.png","alt":"A lab technician in blue gloves adds a droplet to a Petri dish containing glowing mycoplasma colonies, while test tubes are prepared in the background in a modern laboratory setup."},"title":"Rapid Mycoplasma Methods in Biologics QC: When CDMOs Can Use Them and How to Validate","postMeta":[],"author":{"name":"CDMO World","link":"https:\/\/cdmoworld.com\/author\/raismrafiq\/"},"date":"Mar 6, 2026","dateGMT":"2026-03-06 11:12:20","modifiedDate":"2026-03-06 11:12:21","modifiedDateGMT":"2026-03-06 11:12:21","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/cdmoworld.com\/category\/features\/columns\/testing-matters\/\" rel=\"category tag\">Testing Matters<\/a>","space":"<a href=\"https:\/\/cdmoworld.com\/category\/features\/columns\/testing-matters\/\" rel=\"category tag\">Testing Matters<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/cdmoworld.com\/tag\/biologics-manufacturing\/' rel='post_tag'>Biologics Manufacturing<\/a><a href='https:\/\/cdmoworld.com\/tag\/cdmo\/' rel='post_tag'>CDMO<\/a><a href='https:\/\/cdmoworld.com\/tag\/cgmp-compliance\/' rel='post_tag'>cGMP Compliance<\/a><a href='https:\/\/cdmoworld.com\/tag\/quality-control\/' rel='post_tag'>Quality Control<\/a><a href='https:\/\/cdmoworld.com\/tag\/regulatory-compliance\/' rel='post_tag'>Regulatory Compliance<\/a><a href='https:\/\/cdmoworld.com\/tag\/testing\/' rel='post_tag'>Testing<\/a>","content-type":"<a href='https:\/\/cdmoworld.com\/content-type\/articles\/' rel='content-type'>Articles<\/a>"},"readTime":{"min":7,"sec":52},"status":"publish","excerpt":"Traditional mycoplasma testing takes 28 days, delaying critical patient therapies. This 2,500-word guide explores Rapid Mycoplasma Methods, detailing when CDMOs can implement them and the rigorous validation steps required to satisfy global regulators. Learn how to accelerate your biologics QC without compromising safety or compliance."}]
Sponsor or AdvertiseMedia Kit
Latest Tips
Latest Q&A
CDMWorld Footer